Calcium polyphosphate precipitation – A strategy to tune the chain length of the glass and control the subsequent release of vancomycin
Source abstract
Abstract
Abstract Using a multi-variable design approach this study sought to determine whether calcium polyphosphate (CPP) could be precipitated with a significantly higher chain length than achieved with conventional melt-derived glass and subsequently enhance the performance of the CPP-based drug delivery matrix. Manipulating aqueous sodium polyphosphate concentration, order of reactant addition, and Ca/P molar ratio at mix of reactants across a minimum of two levels was found to significantly influence the chain length, Ca/P ratio, and residual sodium of the resulting CPP precipitates. The various interactions of these three variables were also found to have a significant impact on the aforementioned properties of the precipitates and we successfully fabricated a precipitate with a 6-fold increase in chain length over that achieved by conventional melting. Despite not seeing a significant improvement in drug release properties, our systematic preparation of calcium polyphosphate from aqueous sodium polyphosphate solutions yielded valuable mechanistic data on this interesting fabrication strategy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Calcium phosphate bioceramics prepared from wet chemically precipitated powders10.2298/PAC1001045S ↗
2. Calcium phosphate cements as bone drug delivery systems: a review10.1016/j.jconrel.2006.04.007 ↗
3. Physical and chemical properties of calcium phosphates for solid state pharmaceutical formulations10.3109/03639049009114932 ↗
4. Structure and properties of the condensed phosphates. IV. Complex ion formation in polyphosphate solutions10.1021/ja01158a004 ↗
5. Melt-derived condensed polymorphic calcium phosphate as bone substitute material: an in vitro study10.1111/j.1551-2916.2011.04487.x ↗
6. Porous CPP scaffolds for bone substitute applications – in vitro characterization10.1016/S0142-9612(00)00261-1 ↗
7. Dissolution of (50-x)Na2O-xCaO-50P2O5 metaphosphate glasses in different saline solutions: mechanism and kinetic control
8. Porous calcium polyphosphate scaffolds for bone substitute applications in vivo studies10.1016/S0142-9612(01)00336-2 ↗
9. Repair of osteochondral defects with biphasic cartilage-calcium polyphosphate constructs in a Sheep model10.1016/j.biomaterials.2006.03.005 ↗
10. Biodegradable porous calcium polyphosphate scaffolds for the three-dimensional culture of dental pulp cells10.1111/j.1365-2591.2006.01114.x ↗
11. In vivo evaluation of calcium polyphosphate for bone regeneration10.1177/0885328211401933 ↗
12. Calcium polyphosphate as an anti-cancer drug delivery system
13. The effect of polymeric chain-like structure on the degradation and cellular biocompatibility of calcium polyphosphate10.1016/j.msec.2008.04.017 ↗
14. Three-dimensional matrices of CPPs support bone growth in vitro and in vivo
15. Porous calcium polyphosphate as load-bearing bone substitutes: in vivo study10.1002/jbm.b.32832 ↗
16. Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C ↗
17. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells10.1016/j.biomaterials.2003.10.031 ↗
18. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-related behaviors of HUVECs10.1007/s10856-007-3350-9 ↗
19. Preparation of zinc sodium polyphosphates glasses from coacervates precursors. Characterisation of the obtained glasses, and their applications10.1016/S1631-0748(02)01454-6 ↗
20. Effect of polymerization temperature on polymerization degree and structure of calcium polyphosphate
21. Fabrication and characterization of porous CPP scaffolds10.1007/s10853-006-5182-2 ↗
22. Effect of polymerization degree of calcium polyphosphate on its microstructure and in vitro degradation performance10.1007/s10856-007-3235-y ↗
23. Calcium and iron (III) polyphosphate gel formation and aging10.1016/S0927-7757(96)03985-4 ↗
24. Synthesis and dehydration of amorphous calcium phosphate10.1023/A:1017572502092 ↗
25. Synthesis and properties of simple and complex polymetaphosphate glasses of alkali metals10.1351/pac198860081349 ↗
26. Calcium phosphate precipitation at slightly alkaline pH values
27. Colloidal aspects of precipitation processes10.1016/S0009-2509(02)00345-7 ↗
28. Interaction of macro-and micromixing on particle size distribution in reactive precipitation10.1016/0009-2509(96)00053-X ↗
29. On the influence of mixing on crystal precipitation processes—application of the segregated feed model10.1016/S0009-2509(01)00417-1 ↗
30. New technologies for the precipitation of solid particles with controlled properties10.1016/S0032-5910(02)00175-4 ↗
31. A thermochemical approach for calcium phosphate precipitation modeling in a pellet reactor10.1016/S1385-8947(03)00044-5 ↗
32. The effect of processing on the structural characteristics of vancomycin-loaded amorphous CP matrices10.1016/j.biomaterials.2004.11.010 ↗
33. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment10.1016/j.biomaterials.2005.05.072 ↗
34. Compaction strategies for modifying the drug delivery capabilities of gelled CPP matrices10.1016/j.actbio.2007.09.007 ↗
35. Gelled calcium polyphosphate matrices delay antibiotic release10.1177/154405910608500712 ↗
36. Polyphosphates as polyelectrolytes. I. Light scattering and viscosity of sodium polyphosphates in electrolyte Solutions110.1021/ja01112a017 ↗
37. Viscosity behavior of coacervates of magnesium and calcium highpolyphosphates10.1246/bcsj.48.1452 ↗
38. Thermal change of magnesium high polyphosphate coacervates10.1246/bcsj.49.2105 ↗
39. Magnesium polymetaphosphate10.1021/ja01602a014 ↗
40. Kulaev · 2005
41. Antimicrobial treatment of chronic osteomyelitis10.1097/00003086-199903000-00008 ↗
42. New insight on the structural trends of polyphosphate coacervation processes10.1021/jp801585v ↗
43. Spectroscopic study and local coordination of polyphosphate colloidal systems10.1021/la0476837 ↗
44. Understanding polyelectrolyte solutions: macroion condensation with emphasis on the presence of neutral co-solutes10.1080/01442350110078842 ↗
45. Clustering of macroions in solutions of highly asymmetric electrolytes10.1016/S0006-3495(00)76627-6 ↗
46. Microscopic structure of the glassy ionic conductor x·LiF (1−x) LiPO3 from NMR data10.1016/S0022-3093(98)00702-9 ↗
47. A P31 nuclear magnetic resonance study of complexing between Li, Ca, and Mg2 ions and the lower condensed phosphate Polyanions10.1021/ja01091a007 ↗
48. Pyrophosphate structures and reactions: evaluation of electrostatic effects on the pyrophosphates with and without alkali cations10.1021/j100084a045 ↗
49. Biodegradation study of amorphous and crystalline calcium metaphosphate in the SBF and Tris-Buffer solution10.4028/www.scientific.net/KEM.192-195.131 ↗
50. Quantification of anion and cation release from a range of ternary phosphate-based glasses with fixed 45 mol% P2O510.1177/0885328205049396 ↗
51. Investigation of the effect of tablet surface Area/Volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets10.1081/DDC-120003007 ↗
52. Kadri · 2001 · 14